{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:14:25Z","timestamp":1784304865382,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejogrb.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:40:33Z","timestamp":1662702033000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Does the dose or type of gonadotropins affect the reproductive outcomes of poor responders undergoing modified natural cycle IVF (MNC-IVF)?"],"prefix":"10.1016","volume":"278","author":[{"given":"P.","family":"Drakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Guardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mackens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2022.09.005_b0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/09513590.2015.1065481","article-title":"Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders","volume":"31","author":"Polyzos","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/humupd\/dmz046","article-title":"Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: A systematic review and network meta-analysis","volume":"26","author":"Zhang","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmr037","article-title":"The poor responder in IVF: Is the prognosis always poor? A systematic review","author":"Oudendijk","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","article-title":"How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics","volume":"30","author":"Patrizio","year":"2015","journal-title":"Reprod Biomed"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/humupd\/dmw001","article-title":"Trends in \u201cpoor responder\u201d research: Lessons learned from RCTs in assisted conception","volume":"22","author":"Papathanasiou","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0030","first-page":"112","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: A multicenter randomized non-inferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.fertnstert.2017.10.033","article-title":"Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis","volume":"109","author":"Youssef","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.fertnstert.2011.09.052","article-title":"Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders","volume":"96","author":"Kadoch","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2017.08.022","article-title":"Mild stimulation for in vitro fertilization","author":"Nargund","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0050","article-title":"Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders","author":"Moffat","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2003.09.050","article-title":"Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age","volume":"81","author":"Weghofer","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.gyobfe.2007.01.025","article-title":"Le cycle naturel en f\u00e9condation in vitro chez les mauvaises r\u00e9pondeuses","volume":"35","author":"Reyftmann","year":"2007","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0070","doi-asserted-by":"crossref","DOI":"10.1097\/GCO.0000000000000459","article-title":"Added value today of hormonal measurements in ovarian stimulation in gonadotropin-releasing hormone antagonist treatment cycle","author":"Popovic-Todorovic","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0075","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: Two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0080","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/humrep\/der012","article-title":"Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH\/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial","volume":"26","author":"Kyrou","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7827-10-107","article-title":"The optimal duration of progesterone supplementation in pregnant women after IVF\/ICSI: A meta-analysis","author":"Liu","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2020.03.005","article-title":"Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis","author":"Datta","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0095","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2003.11.031","article-title":"A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization","volume":"81","author":"Morgia","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0100","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.fertnstert.2009.06.005","article-title":"Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0105","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/humrep\/dev198","article-title":"Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders","volume":"30","author":"Lainas","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0110","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2019poor response to ovarian stimulation for in vitro fertilization: The Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dev272","article-title":"Modified natural cycle IVF for poor ovarian responders: Rethink before concluding","author":"Polyzos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.fertnstert.2014.02.036","article-title":"Is the modified natural in vitro fertilization cycle justified in patients with \u201cgenuine\u201d poor response to controlled ovarian hyperstimulation?","volume":"101","author":"Kedem","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0125","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.rbmo.2019.05.009","article-title":"Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders","volume":"39","author":"Drakopoulos","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-013-9947-7","article-title":"Ovarian stimulation protocols for onco-fertilty patients","author":"Koch","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0140","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0145","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: An RCT. Part 1: The predicted poor responder","volume":"32","author":"Van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0160","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ejogrb.2022.09.005_b0165","article-title":"The novel POSEIDON stratification of \u201cLow prognosis patients in Assisted Reproductive Technology\u201d and its proposed marker of successful outcome","volume":"5","author":"Esteves","year":"2016","journal-title":"F1000Research"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522004997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:36:56Z","timestamp":1773826616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522004997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"alternative-id":["S0301211522004997"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.09.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the dose or type of gonadotropins affect the reproductive outcomes of poor responders undergoing modified natural cycle IVF (MNC-IVF)?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}